Intellia Therapeutics, Inc.
- Stock
- Ticker NTLA
- ISIN US45826J1051
- Nasdaq
Performance, volatility and drawdowns of Intellia Therapeutics, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $5,621. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −96.4% in 04/2025, measured from the peak in 09/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 13 | 17 | 14 | 14 | 23 | 15 | 7.7 | 7.2 |
| Operating income | -136 | -121 | -110 | -111 | -99 | -101 | -113 | -122 |
| EBITDA | -134 | -118 | -107 | -109 | -96 | -98 | -111 | -120 |
| Net income | -129 | -114 | -101 | -101 | -96 | -96 | -107 | -127 |
| Earnings per share | -1.26 | -1.10 | -0.98 | -0.92 | -0.82 | -0.81 | -0.80 | -0.91 |
| Balance sheet | ||||||||
| Total assets | 1,191 | 986 | 899 | 925 | 842 | 759 | 857 | 903 |
| Liabilities | 319 | 206 | 184 | 177 | 171 | 138 | 129 | 289 |
| Equity | 872 | 780 | 715 | 748 | 671 | 621 | 728 | 613 |
| Cash | 189 | 127 | 156 | 193 | 155 | 135 | 106 | 156 |
| Long-term debt | – | – | – | – | 0.0 | – | – | 74 |
| Cash flow | ||||||||
| Operating cash flow | -85 | -149 | -100 | -77 | -69 | -117 | -83 | -85 |
| Capital expenditure | -1.0 | -0.7 | -0.2 | 0.0 | -0.1 | -0.1 | -1.8 | -0.9 |
| Free cash flow | -86 | -150 | -100 | -77 | -69 | -117 | -85 | -86 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +270.8%, weakest 2022 at −70.5%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.91 |
| 6 Aug 2026 | −$0.80 |
| 11 May 2026 | −$0.81 |
| 26 Feb 2026 | −$0.82 |
| 6 Nov 2025 | −$0.92 |
| 7 Aug 2025 | −$0.98 |
| 8 May 2025 | −$1.10 |
| 27 Feb 2025 | −$1.26 |
| 7 Nov 2024 | −$1.34 |
| 8 Aug 2024 | −$1.52 |
| 9 May 2024 | −$1.12 |
| 22 Feb 2024 | −$1.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.3bn
- Market cap in trading currency
- $1.40bn
- Enterprise value
- $1.00bn
- P/E
- –
- P/S
- 26.54
- P/B
- 2.29
- EV/Sales
- 18.97
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -25.5%
Results (last four quarters)
- Revenue
- $52.9m
- Gross profit
- –
- EBITDA
- −$426m
- Net income
- −$426m
- Earnings per share
- −$3.34
- Revenue per share
- $0.38
- Revenue growth
- −48.0%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -821.2%
- Net margin
- -805.7%
- Return on equity
- -62.6%
- Return on assets
- -47.2%
Balance sheet and cash flow
- Cash
- $474m
- Cash per share
- $3.38
- Financial debt
- $73.7m
- Debt/equity %
- 12
- Current ratio
- 6.31
- Book value per share
- $4.37
- Operating cash flow
- −$355m
- Free cash flow
- −$358m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 140m
- Volume
- 15.2m
- Avg. volume 3 months
- 4.65m
- Relative volume
- 3.1
Price and technicals
- Price
- $10.00
- 1 day
- +5.0%
- 52-week high
- $17.84
- 52-week low
- $8.04
- Distance to 52-week high
- −43.9%
- Distance to 52-week low
- +24.4%
- Distance to 50-day line
- −14.3%
- Distance to 200-day line
- −22.4%
- RSI (14)
- 41
- Volatility 1M
- 88.6%
Performance
- 1 week
- +3.1%
- 1 month
- −10.4%
- 3 months
- −20.4%
- 6 months
- −20.6%
- YTD
- +11.2%
- 1 year
- +21.4%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has NTLA performed since 11/2016?
$10,000 grew to $5,621 by 20 Nov 2026, which is −5.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is NTLA?
Volatility was 78.6% per year, measured on monthly returns. The largest decline from a peak was −96.4%, with the low in 04/2025.
How does NTLA compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, NTLA returned −5.6% at 78.6%. The correlation of monthly returns was 0.40; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.